Medicare's GLP-1 Bridge program launches July 1, offering $50 copays for weight loss drugs like Wegovy and Zepbound. Check ...

RoenRx, a telehealth platform providing medically supervised weight-loss care, today released updated 2026 pricing ...

Medicare's upcoming weight-loss drug program could create major bottlenecks for doctors as millions of seniors seek access to ...

We break down Fridays weight loss plans, GLP-1 pricing, reviews and safety concerns in this expert-backed guide.

CVS Health will reinstate coverage of Eli Lilly's weight-loss injectable Zepbound and begin coverage of the anti-obesity pill Foundayo.

Tirzepatide is the active ingredient in an injectable medication (Zepbound) approved by the U.S. Food and Drug Administration ...

Starting July 1, about 14 million people on Medicare who have been diagnosed as obese or overweight will be eligible for $50 ...

A population-wide rollout of GLP-1 medication could solve the obesity epidemic and reduce the rates of other diseases ...